Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism

Journal of Child Neurology

Volumn 14, Issue 6, 1999, Pages 388-394

  Comi, Anne M ^a   Zimmerman, Andrew W ^b   Frye, Virginia H ^b   Law, Paul A ^b   Peeden, Joseph N ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032989380     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400608     Document Type: Article

References (33)

1. Rapin I: Autism. N Engl J Med 1997;337:97-103.
2. Zimmerman AW, Frye VH, Potter NT: Immunological aspects of autism. Int Pediatr 1993;8:199-204.
3. Gillberg C, Coleman M, in The Biology of the Autistic Syndromes, 2nd ed. Oxford, MacKeith, 1992, pp 96-114.
4. Ritvo ER, Jorde LB, Mason-Brothers A, et al: The UCLA-University of Utah epidemiologic survey of autism: Recurrence risk estimates and genetic counseling. Am J Psychiatry 1989;146: 1032-1036.
5. Bailey A, Le Counteur A, Gottesman I, et al: Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 1995;25:63-77.
6. Money J, Bobrow NA, Clark FC: Autism and autoimmune disease: A family study. J Autism Child Schizophr 1971;1:146-160.
7. Denney DR, Frei BW, Gaffney GR: Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 1996; 26:87-97.
8. Gupta S, Aggarwal S, Heads C: Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. J Autism, Dev Disord 1996;26:439-452.
9. Plioplys AV, Greaves A, Kazemi K, Silverman E: Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 1994;29: 12-16.
10. Singh VK, Warren RP, Odell JD, et al: Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993;7:97-103.
11. van Gent T, Heijen CJ, Treffers PDA: Autism and the immune system. J Child Psychol Psychiatry 1997;39:337-349.
12. Plioplys AV: Intravenous immunoglobulin treatment of children with autism. J Child Neurol 1998;13:79-82.
13. Dalakas MC: Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 1997;126:721-730.
14. Buitelaar JK, van Engeland H, van Ree JM, de Wied D: Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children. J Autism Dev Disord 1990;24:467-478.
15. Buitelaar JK, van Engeland H, de Kogel CH, et al: Deficits in social behavior in autism and their modification by a synthetic adrenocorticotrophic hormone (4-9). Analog Experientia 1994;48:391-394.
16. Daniels WW, Warre RP, Odell JD, et al: Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Biol Psychiatry 1995;2:120-123.
17. Warren RP, Odell JD, Warren WL, et al: Strong association of the third hypervariable region of HLA-DR B1 with autism. J Neuroimmunol 1996;67:97-102.
18. Warren RP, Singh VK, Cole P, et al: Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 1992;36:203-207.
19. Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell 1996;85:311-318.
20. Kotzin BL: Systemic lupus erythematosus. Cell 1996;85:303-306.
21. Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-2126.
22. Folstein SE, Piven J: Etiology of autism: Genetic influences. Pediatrics 1991;87(Suppl):767-773.
23. Bolton PF, Murphy M, MacDonald H, et al: Obstetric complications in autism: Consequences or causes of the condition? J Am Acad Child Adolesc Psychiatry 1997;36:272-281.
24. Bidet B, Leyboyer M, Descours B, et al: Allergic sensitization in infantile autism, letter. J Autism Dev Disord 1993;23:419-420.
25. Renzoni E, Beltrami V, Sestini P, et al: Brief report: Allergological evaluation of children with autism. J Autism Dev Disord 1995;25:327-333.
26. Lucaelli S, Frediani T, Zingoni AM, et al: Food allergy and infantile autism. Panminerva Med 1995;37:137-141.
27. Cook EH, Courchesne R, Lord C, Cox NJ: Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997;2:247-250.
28. Bauman ML, Kemper TL (eds): The Neurobiology of Autism. Baltimore, Johns Hopkins University Press, 1994.
29. Root-Bernstein RS, Westall FC: Serotonin binding sites. II. Muramyl dipeptide binds to serotonin binding sites on myelin basic protein, LHRH, and MSH-ACTH 4-10. Brain Res Bull 1990;25:827-841.
30. Mott SH, Weinstein SL, Conry JA, et al: Pervasive developmental disorder/autism versus Landau-Kleffner syndrome: Steroid responsive encephalopathy characterized by language and social interactive impairment. Ann Neurol 1996;40:332.
31. Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 1993;329:1246-1253.
32. Silverman DHS, Imam K, Karnovsky ML: Muramyl peptide/serotonin receptors in brain-derived preparations. J Pep Res 1989;2: 338-344.
33. Mehler MF, Kesslar JA: Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 1997;20: 357-365.